AKRO - Akero Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
4.50B
Volume:
11,609,142
Avg Volume:
2,562,198
52 Week Range:
21.34-58.4
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-0.40
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
69
IPO Date:
2019-06-20
EPS (TTM):
-3.75
P/E Ratio:
-7.41
Revenue (TTM):
N/A
Total Assets:
825.89M
Total Debt:
36.46M
Cash & Equiv:
340.24M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-31.5%
Debt/Equity:
0.05
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-07 | $-0.99 | $-0.94 | -5.3% | — | — | — |
| 2025-08-08 | $-0.86 | $-0.97 | +11.3% | — | — | — |
| 2025-05-12 | $0.90 | $-1.01 | +189.1% | — | — | — |
| 2025-02-28 | $-0.99 | $-0.98 | -1.0% | — | — | — |
| 2024-11-08 | $-1.05 | $-0.90 | -16.7% | — | — | — |
| 2024-08-09 | $-0.81 | $-0.90 | +10.0% | — | — | — |
| 2024-05-10 | $-0.90 | $-0.90 | 0.0% | — | — | — |
| 2024-02-29 | $-0.99 | $-0.82 | -20.7% | $284000 | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (252.06M) | (151.76M) | (112.03M) | (100.78M) | (79.19M) | (43.76M) | (81.71M) | (4.56M) |
| EPS | -3.75 | -2.89 | -2.87 | -2.89 | -2.52 | -2.90 | -3.85 | -0.16 |
| Total Assets | 825.89M | 580.27M | 356.57M | 195.55M | 273.34M | 138.12M | 77.15M | 658,000 |
| Total Debt | 36.46M | 26.30M | 10.95M | 1.52M | 1.81M | 85,000 | 0 | 0 |
| Cash & Equivalents | 340.24M | 234.21M | 249.77M | 150.48M | 187.24M | 64.79M | 75.97M | 598,000 |
| Operating Cash Flow | (230.11M) | (145.37M) | (92.52M) | (79.68M) | (70.80M) | (35.63M) | (4.62M) | (4.38M) |
| Free Cash Flow | (231.11M) | (145.37M) | (92.52M) | (79.68M) | (70.95M) | (35.63M) | (9.62M) | (4.38M) |
| FCF per Share | -3.44 | -2.77 | -2.37 | -2.29 | -2.26 | -2.36 | -0.45 | -0.15 |
| Book Value | 750.11M | 535.31M | 326.56M | 169.11M | 258.71M | 128.73M | (49.92M) | (4.56M) |
| Cash & ST Investments | 743.08M | 550.01M | 351.45M | 188.26M | 268.39M | 136.40M | 75.97M | 598,000 |
| ROC Equity | -0.34 | -0.28 | -0.34 | -0.60 | -0.31 | -0.34 | N/A | N/A |